Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Aug 3;12(1):13353.
doi: 10.1038/s41598-022-17632-y.

The prevalence of human papillomavirus among women in northern Guangdong Province of China

Affiliations

The prevalence of human papillomavirus among women in northern Guangdong Province of China

Wenbo Huang et al. Sci Rep. .

Abstract

Globally, cervical cancer, whose etiologic factor is Human papillomavirus (HPV), is the third most common cancer among women. In cervical cancer screening, HPV testing is important. However, the prevalence of HPV in northern Guangdong Province has not been conclusively determined. A total of 100,994 women attending Yuebei People's Hospital Affiliated to Shantou University Medical College between 2012 and 2020 were recruited. HPV was tested by a polymerase chain reaction (PCR)-based hybridization gene chip assay. The prevalence of HPV among these women was established to be19.04%. Peak prevalence was observed in women aged 40-49 (7.29%). Besides, the prevalence of single-type HPV infection (14.46%) was significantly high, compared to multiple-type infection (4.58%) (p < 0.01), while the prevalence of high-risk HPV infection (19.97%) was significantly higher than that of low-risk genotypes (5.48%) (p < 0.01). The most prevalent high-risk genotypes were HPV52 (4.16%), HPV16 (2.98%), HPV58 (2.15%), HPV53 (1.58%) and HPV68 (1.34%). HPV co-infection with up to 10 genotypes was reported for the first time. Our findings suggested a high burden of HPV infections among women in northern Guangdong. Establishing the prevalence and genotype distribution characteristics of HPV infections in the region can contribute to cervical cancer prevention through HPV vaccination.

PubMed Disclaimer

Conflict of interest statement

The authors declare no competing interests.

Figures

Figure 1
Figure 1
HPV infection rate in different age groups.
Figure 2
Figure 2
HPV infection rate from 2012 to 2020.
Figure 3
Figure 3
Distribution of HR-HPV subtypes infection.
Figure 4
Figure 4
Distribution of LR-HPV subtypes infection.
Figure 5
Figure 5
(a) HPV positive coinfection with 10 subtypes; (b) HPV negative ybridization.

Similar articles

Cited by

References

    1. Arbyn M, Weiderpass E, Bruni L, de Sanjosé S, Saraiya M, Ferlay J, et al. Estimates of incidence and mortality of cervical cancer in 2018: a worldwide analysis. Lancet Glob. Health. 2020;8:e191–e203. doi: 10.1016/S2214-109X(19)30482-6. - DOI - PMC - PubMed
    1. Crosbie EJ, Einstein MH, Franceschi S, Kitchener HC. Human papillomavirus and cervical cancer. Lancet. 2013;382:889–899. doi: 10.1016/S0140-6736(13)60022-7. - DOI - PubMed
    1. Lei J, Ploner A, Elfström KM, Wang J, Roth A, Fang F, et al. HPV vaccination and the risk of invasive cervical cancer. N. Engl. J. Med. 2020;383:1340–1348. doi: 10.1056/NEJMoa1917338. - DOI - PubMed
    1. World Health Organization Human papillomavirus vaccines: WHO position paper. May 2017-Recommendations. Vaccine. 2017;35:5753–5755. doi: 10.1016/j.vaccine.2017.05.069. - DOI - PubMed
    1. Kreisel KM, Spicknall IH, Gargano JW, Lewis FMT, Lewis RM, Markowitz LE, et al. Sexually transmitted infections among US women and men: Prevalence and incidence estimates, 2018. Sex Transm Dis. 2021;48:208–214. doi: 10.1097/OLQ.0000000000001355. - DOI - PMC - PubMed

Publication types